We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 662

Defining the bounds of the public disclosure bar and the scope of "news media"

  • Jones Day
  • -
  • USA
  • -
  • April 15 2015

On March 3, 2015, a court in the Southern District of Texas granted a defendant pharmaceutical company's motion for summary judgment on claims

Claim construction, findings of fact, and indefiniteness in the wake of Teva v. Sandoz

  • Jones Day
  • -
  • USA
  • -
  • April 14 2015

In its January 2015 decision in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., the United States Supreme Court held, contrary to the Federal

Pharmaceutical & medical device regulatory update, vol. II, issue 7

  • Jones Day
  • -
  • USA
  • -
  • April 10 2015

Last week, Margaret A. Hamburg completed a nearly six-year stint as FDA Commissioner. In a departing interview with National Public Radio, Hamburg

Federal Circuit addresses jurisdiction to review stay orders in covered business method reviews

  • Jones Day
  • -
  • USA
  • -
  • April 9 2015

In Intellectual Ventures II LLC v. JPMorgan Chase & Co., a 21 decision issued on April 1, 2015, the Federal Circuit held that it lacked jurisdiction

Antitrust alert: U.S. DOJ brings renewed attention to antitrust compliance programs

  • Jones Day
  • -
  • USA
  • -
  • April 8 2015

On March 31, 2015, a federal court issued a summons to AU Optronics Corporation ("AU Optronics") to respond to allegations that it violated its

Foreign representative lacks standing to assert state-law avoidance claims in chapter 15 case

  • Jones Day
  • -
  • USA
  • -
  • March 31 2015

In Hosking v. TPG Capital Management LP (In re Hellas Telecommunications (Luxemburg) II SCA), 2015 BL 21823 (Bankr. S.D.N.Y. Jan. 29, 2015), the U.S

Tender offer approved to implement classwide debt exchange outside plan of reorganization

  • Jones Day
  • -
  • USA
  • -
  • March 31 2015

Debt-for-equity swaps and debt exchanges are common features of out-of-court as well as chapter 11 restructurings. For publicly traded securities

Pharmaceutical & medical device regulatory update, vol. II, issue 6

  • Jones Day
  • -
  • USA
  • -
  • March 27 2015

A federal court in California has ruled that under the Biologics Price Competition and Innovation Act ("BPCI Act") a biosimilar applicant is not

Supreme Court clarifies liability standard for opinions expressed in registration statements

  • Jones Day
  • -
  • USA
  • -
  • March 26 2015

On March 24, 2015, the United States Supreme Court clarified the circumstances under which a company can be liable under 11 of the Securities Act

Key patent law decisions of 2014

  • Jones Day
  • -
  • USA
  • -
  • March 26 2015

Since the creation of the United States Court of Appeals for the Federal Circuit almost three decades ago, the number of U.S. Supreme Court cases